GLP-1R agonists exert broad antiinflammatory effects in multiple peripheral organs, including the central nervous system, lungs, cardiovascular system, liver, intestine, kidneys, and joints
Facing health issues and significant weight gain was tough, but finding the right treatment changed everything
It found a 20% reduction in major adverse cardiovascular events - heart attacks, strokes, and cardiovascular death - with FDA-approved Wegovy in a population with established cardiovascular disease and overweight or obesity
And thats even with a muscle-building boost from TRT, says Priya Jaisinghani, M.D., an endocrinologist and obesity-medicine expert at NYU Langone Health
This FDAapproved injectable medication has become a cornerstone in medically-supervised weight loss